Today: 30 April 2026
Meta stock price holds near $604 as FTC appeal revives antitrust cloud ahead of earnings
21 January 2026
1 min read

Meta stock price holds near $604 as FTC appeal revives antitrust cloud ahead of earnings

New York, Jan 21, 2026, 10:13 EST — Regular session underway.

  • Meta shares slipped slightly in morning action, lagging behind the broader U.S. stock rally.
  • The FTC said it will appeal following a court’s dismissal of its bid to undo Meta’s purchases of Instagram and WhatsApp.
  • Just ahead of Meta’s earnings report on Jan. 28, CTO Andrew Bosworth unveiled a new AI update.

Shares of Meta Platforms (META.O) ticked higher by 31 cents to $604.43 in early Wednesday action. The stock swung within a range from $600.24 to $608.60. On the broader market front, the S&P 500-tracking SPDR fund climbed around 0.7%, while the Invesco QQQ Trust, which follows the Nasdaq 100, gained about the same.

The tape stayed flat after the U.S. Federal Trade Commission said it will appeal a judge’s dismissal of its antitrust suit seeking to force Meta to divest Instagram and WhatsApp. “Our position has not changed,” FTC spokesperson Joe Simonson said following the November ruling, which concluded Meta is not a monopoly due to competition from TikTok. Reuters

Legal clouds have reappeared just days before Meta’s earnings announcement. The company is set to release its Q4 and full-year results after markets close on Jan. 28, with a conference call scheduled for 4:30 p.m. ET.

UK regulators have intensified scrutiny on Meta after the UK Gambling Commission accused the firm of turning a blind eye to illegal online casino ads on Facebook and Instagram. Executive director Tim Miller called Meta’s denial of awareness “simply false.” Meta pushed back, saying it enforces strict rules on gambling ads and takes down any that breach its policies when identified. Reuters

Meta’s CTO Andrew Bosworth told reporters in Davos that its new Meta Superintelligence Labs team launched its first major AI models internally this month, calling the outcomes “very good.” He highlighted that Meta is starting to see returns from infrastructure investments made in 2025. Bosworth also revealed the company paused international rollout of its AI-powered Ray-Ban Display glasses earlier this month, opting to prioritize U.S. orders instead. Reuters

Investors are zeroed in on Meta’s speed in turning AI models into ad tools and consumer products, not merely on expanding data centers or grappling with rising energy expenses. The real stock movers are those AI-driven updates.

Sentiment around the stock has turned cautious. With appeals dragging on, any renewed lawsuit stokes a distant yet significant threat: the potential forced sale of crucial assets that drive Meta’s ad business.

There’s a simpler risk at play. Tighter ad regulations, sluggish consumer demand, or a fresh spike in costs could pinch margins in 2026 guidance—especially if revenue gains from AI-driven growth don’t ramp up as fast as bulls expect.

Traders are zeroing in on the Jan. 28 report along with management’s guidance on spending and upcoming product launches. News on the appeals process could shake a market already braced for impact.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Energy Fuels (UUUU) stock jumps premarket as $300 million ASM deal puts rare-earth supply chain in focus
Previous Story

Energy Fuels (UUUU) stock jumps premarket as $300 million ASM deal puts rare-earth supply chain in focus

AMD stock jumps 6% as earnings countdown starts and valuation debate flares
Next Story

AMD stock jumps 6% as earnings countdown starts and valuation debate flares

Go toTop